Category: KneesSyndicate content

Knees

Smith & Nephew gains on Q1 results

May 3, 2012 by MassDevice staff

MassDevice.com news

Shares of Smith & Nephew (FTSE:SN, NYSE:SNN) are up nearly 4% today after the British health products giant posted sales and earnings increases for the 1sst quarter.

Zimmer slides on Q1 results

April 26, 2012 by MassDevice staff

Zimmer Holdings shares slide 5% ahead of its 1st-quarter results showing Street-meeting earnings but lackluster sales of hip and knee implants.

MassDevice.com news

Investors sent shares of Zimmer (NYSE:ZMH) down 5% this morning in pre-market trading after the orthopedic device maker reported sales and earnings in-line with Wall Street's expectations, but lackluster sales of hip and knee implants.

The Warsaw, Ind.-based company posted profits of $209.6 million, or $1.17 per diluted share, on sales of $1.14 billion for the 3 months ended March 31.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Democratic "buyers' remorse" for health care law? | MassDevice.com On Call

April 20, 2012 by MassDevice staff

A growing number of Democratic legislators are raising concerns about President Barack Obama's landmark health care reform ahead of election season.

MassDevice On Call

MASSDEVICE ON CALL — A growing number of Democrats are voicing concerns about President Barack Obama's Affordable Care Act ahead of election season, Healthwatch reported.

Criticisms came from both houses of Congress, including Rep. Dennis Cardoza (D-Calif.), Rep. Brad Miller (D-N.C.), Rep. Barney Frank (D-Mass.), Sen. Jim Webb (D-Va.) who wondered whether the measures came too fast and too soon.

Orthopedic survey: U.S. knee/hip market has hit bottom

April 13, 2012 by MassDevice staff

A survey of orthopedic docs by investment bank Leerink Swann yields mixed messages for the U.S. market for hip and knee reconstructions.

The U.S. market for hip and knee reconstructions may have hit bottom, but there's still a long way to go, according to a survey of orthopedic surgeons.

The investment bank Leerink Swann polled 76 "high volume" orthopedic surgeons, concluding that the knee and hip reconstruction market is "stable" but not "improving," with most knee and hip docs reporting unchanged patient surgery wait times and "only modest expectations in their next 12 month procedure growth forecasts."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ConforMIS calls out Stanmore Implants on custom knee patents

March 21, 2012 by MassDevice staff

ConforMIS contests Stanmore Implants' claims to a custom knee implant replacement system patent with the U.S. Patent & Trademark Office.

ConfoMIS logo

Burlington, Mass.-based ConforMIS filed documents officially contesting a patent application for a personalized knee replacement system that Stanmore Implants claims to be the world's 1st.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude's Riata recall evidence of nationwide issue, doc says | MassDevice.com On Call

March 6, 2012 by MassDevice staff

The problems with St. Jude Medical's Riata lead, which the company eventually recalled, could have been caught earlier if not for lax policies and practices at the FDA, according to Minneapolis Heart Institute's Dr. Robert Hauser.

MassDevice On Call

MASSDEVICE ON CALL — The problems with St. Jude Medical's (NYSE:STJ) recalled Riata defibrillator leads should have been caught sooner, according to a prominent heart doctor.

Dr. Robert Hauser, of the Minneapolis Heart Institute, in an article for the New England Journal of Medicine, wrote that problems with the leads, which remain active in an estimated 79,000 U.S. patients, went uncovered for too long because of lax post-market surveillance.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp